Secor Capital Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

Secor Capital Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-72,275	Closed	-$1.45M	–	641
2018 Q3	$1.45M	Buy	72,275 +26,745	+59%	+$609K	0.16%	202
2018 Q2	$888K	Buy	+45,530	New	+$1.01M	0.08%	319
2016 Q4	–	Sell	-34,904	Closed	-$855K	–	668
2016 Q3	$855K	Buy	+34,904	New	+$872K	0.09%	279
2014 Q1	–	Sell	-13,542	Closed	-$329K	–	415
2013 Q4	$329K	Buy	+13,542	New	+$319K	0.13%	248

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Secor Capital Advisors's AMAG Position: Q4 2018 in Review

Secor Capital Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q4 2018, closing a stake of 72,275 shares — an estimated $1.45M sold.

Secor Capital Advisors first reported a position in AMAG in Q4 2013 and held it in 4 quarters. The position peaked at $1.45M in Q3 2018. 190 funds tracked by Wall St. Rank hold AMAG as of Q4 2018.

Secor Capital Advisors reported no remaining AMAG Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Secor Capital Advisors sold 72,275 AMAG Pharmaceuticals shares in Q4 2018, an estimated $1.45M.
Secor Capital Advisors first reported a position in AMAG Pharmaceuticals in Q4 2013 and held it in 4 quarters.
Secor Capital Advisors's AMAG Pharmaceuticals position peaked at $1.45M in Q3 2018.
190 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2018.

Based on Secor Capital Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.